Trial intelligence / Profile preview

Foley catheter versus oral misoprostol for induction of labour at term

NL-OMON39523Phase 3Active, not recruiting

Sponsor
Amsterdam University Medical Center
Start
Jul 2012
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, open-label trial of misoprostol (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoints: Composite complications of uterine hyperstimulation and Instrumental delivery rate. Started Jul 2012; status: active, not recruiting.

02

Drugs

misoprostol

Beyond the preview

Go deeper on NL-OMON39523.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON39523.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call